Diabetes, Vol 49, Issue 2 272-283, Copyright © 2000 by American Diabetes Association

ARTICLES

Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity

A Basu, R Basu, P Shah, A Vella, CM Johnson, KS Nair, MD Jensen, WF Schwenk and RA Rizza
Department of Endocrinology, Mayo Foundation, Rochester, Minnesota 55905, USA.

Insulin-induced stimulation of muscle glucose uptake (MGU) is impaired in people with type 2 diabetes. To determine whether insulin-induced stimulation of splanchnic glucose uptake (SGU) is also impaired, we simultaneously measured leg glucose uptake (LGU) and SGU in 14 nondiabetic subjects and 16 subjects with type 2 diabetes using a combined organ catheterization-tracer infusion technique. Glucose was clamped at approximately 9.3 mmol/l, while insulin concentrations were maintained at approximately 72 pmol/l (low) and approximately 150 pmol/l (high) for 3 h each. Endogenous hormone secretion was inhibited with somatostatin. Total body glucose disappearance was lower (P < 0.01) and glucose production higher (P < 0.01) during both insulin infusions in the diabetic compared with the nondiabetic subjects, indicating insulin resistance. Splanchnic glucose production was higher (P < 0.05) in the diabetic subjects during the low but not the high insulin infusion. SGU was slightly lower in the diabetic than in the nondiabetic subjects during the low insulin infusion and 50-60% lower (P < 0.05) during the high insulin infusion. LGU (P < 0.001), but not SGU, was inversely correlated with the degree of visceral adiposity. The contribution of the indirect pathway to hepatic glycogen synthesis did not differ in the diabetic and nondiabetic subjects. In contrast, both flux through the UDP-glucose pool (P < 0.05) and the contribution of the direct pathway to glycogen synthesis (P < 0.01) were lower in the diabetic than in the nondiabetic subjects, indicating decreased uptake and/or phosphorylation of extracellular glucose. On the other hand, glycogenolysis was equally suppressed in both groups. In summary, type 2 diabetes impairs the ability of insulin to stimulate both MGU and SGU. The defect appears to reside at a proximal (e.g., glucokinase) metabolic step and is not related to the degree of visceral adiposity. These data suggest that impaired hepatic glucose uptake as well as MGU contribute to hyperglycemia in people with type 2 diabetes.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L. Agius Targeting Hepatic Glucokinase in Type 2 Diabetes: Weighing the Benefits and Risks Diabetes, January 1, 2009; 58(1): 18 - 20. [Full Text] [PDF]

				R. Basu, A. Basu, M. Grudzien, P. Jung, P. Jacobson, M. Johnson, R. Singh, M. Sarr, and R. A. Rizza Liver Is the Site of Splanchnic Cortisol Production in Obese Nondiabetic Humans Diabetes, January 1, 2009; 58(1): 39 - 45. [Abstract] [Full Text] [PDF]

				J. M. Peterson, Y. Wang, R. W. Bryner, D. L. Williamson, and S. E. Alway Bax signaling regulates palmitate-mediated apoptosis in C2C12 myotubes Am J Physiol Endocrinol Metab, December 1, 2008; 295(6): E1307 - E1314. [Abstract] [Full Text] [PDF]

				I. R. Lanza, D. K. Short, K. R. Short, S. Raghavakaimal, R. Basu, M. J. Joyner, J. P. McConnell, and K. S. Nair Endurance Exercise as a Countermeasure for Aging Diabetes, November 1, 2008; 57(11): 2933 - 2942. [Abstract] [Full Text] [PDF]

				F. Sato, Y. Tamura, H. Watada, N. Kumashiro, Y. Igarashi, H. Uchino, T. Maehara, S. Kyogoku, S. Sunayama, H. Sato, et al. Effects of Diet-Induced Moderate Weight Reduction on Intrahepatic and Intramyocellular Triglycerides and Glucose Metabolism in Obese Subjects J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3326 - 3329. [Abstract] [Full Text] [PDF]

				J.-S. Shin, T. P. Torres, R. L. Catlin, E. P. Donahue, and M. Shiota A defect in glucose-induced dissociation of glucokinase from the regulatory protein in Zucker diabetic fatty rats in the early stage of diabetes Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1381 - R1390. [Abstract] [Full Text] [PDF]

				S. Salinari, A. Bertuzzi, A. Gandolfi, A. V. Greco, A. Scarfone, M. Manco, and G. Mingrone Dodecanedioic acid overcomes metabolic inflexibility in type 2 diabetic subjects Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E1051 - E1058. [Abstract] [Full Text] [PDF]

				Y. Fujimoto, T. P. Torres, E. P. Donahue, and M. Shiota Glucose Toxicity Is Responsible for the Development of Impaired Regulation of Endogenous Glucose Production and Hepatic Glucokinase in Zucker Diabetic Fatty Rats Diabetes, September 1, 2006; 55(9): 2479 - 2490. [Abstract] [Full Text] [PDF]

				M. Flores-Diaz, A. Alape-Giron, G. Clark, B. Catimel, Y. Hirabayashi, E. Nice, J.-M. Gutierrez, R. Titball, and M. Thelestam A Cellular Deficiency of Gangliosides Causes Hypersensitivity to Clostridium perfringens Phospholipase C J. Biol. Chem., July 22, 2005; 280(29): 26680 - 26689. [Abstract] [Full Text] [PDF]

				R. Basu, R. J. Singh, A. Basu, E. G. Chittilapilly, M. C. Johnson, G. Toffolo, C. Cobelli, and R. A. Rizza Obesity and Type 2 Diabetes Do Not Alter Splanchnic Cortisol Production in Humans J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3919 - 3926. [Abstract] [Full Text] [PDF]

				R. Basu, V. Chandramouli, B. Dicke, B. Landau, and R. Rizza Obesity and Type 2 Diabetes Impair Insulin-Induced Suppression of Glycogenolysis as Well as Gluconeogenesis Diabetes, July 1, 2005; 54(7): 1942 - 1948. [Abstract] [Full Text] [PDF]

				D. B. Olsen, M. Sacchetti, F. Dela, T. Ploug, and B. Saltin Glucose clearance is higher in arm than leg muscle in type 2 diabetes J. Physiol., June 1, 2005; 565(2): 555 - 562. [Abstract] [Full Text] [PDF]

				M. Shiota, P. Galassetti, K. Igawa, D. W. Neal, and A. D. Cherrington Inclusion of low amounts of fructose with an intraportal glucose load increases net hepatic glucose uptake in the presence of relative insulin deficiency in dog Am J Physiol Endocrinol Metab, June 1, 2005; 288(6): E1160 - E1167. [Abstract] [Full Text] [PDF]

				E. Wajcberg, Y. Miyazaki, C. Triplitt, E. Cersosimo, and R. A. DeFronzo Dose-Response Effect of a Single Administration of Oral Hexyl-Insulin Monoconjugate 2 in Healthy Nondiabetic Subjects Diabetes Care, December 1, 2004; 27(12): 2868 - 2873. [Abstract] [Full Text] [PDF]

				M. Krssak, A. Brehm, E. Bernroider, C. Anderwald, P. Nowotny, C. D. Man, C. Cobelli, G. W. Cline, G. I. Shulman, W. Waldhausl, et al. Alterations in Postprandial Hepatic Glycogen Metabolism in Type 2 Diabetes Diabetes, December 1, 2004; 53(12): 3048 - 3056. [Abstract] [Full Text] [PDF]

				C. Bouche, S. Serdy, C. R. Kahn, and A. B. Goldfine The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes Endocr. Rev., October 1, 2004; 25(5): 807 - 830. [Abstract] [Full Text] [PDF]

				Y. Fujimoto, E. P. Donahue, and M. Shiota Defect in glucokinase translocation in Zucker diabetic fatty rats Am J Physiol Endocrinol Metab, September 1, 2004; 287(3): E414 - E423. [Abstract] [Full Text] [PDF]

				R. Basu, A. Basu, C. M. Johnson, W. F. Schwenk, and R. A. Rizza Insulin Dose-Response Curves for Stimulation of Splanchnic Glucose Uptake and Suppression of Endogenous Glucose Production Differ in Nondiabetic Humans and Are Abnormal in People With Type 2 Diabetes Diabetes, August 1, 2004; 53(8): 2042 - 2050. [Abstract] [Full Text] [PDF]

				R. Basu, R. J. Singh, A. Basu, E. G. Chittilapilly, C. M. Johnson, G. Toffolo, C. Cobelli, and R. A. Rizza Splanchnic Cortisol Production Occurs in Humans: Evidence for Conversion of Cortisone to Cortisol Via the 11-{beta} Hydroxysteroid Dehydrogenase (11{beta}-HSD) Type 1 Pathway Diabetes, August 1, 2004; 53(8): 2051 - 2059. [Abstract] [Full Text] [PDF]

				P. Iozzo, A. K. Turpeinen, T. Takala, V. Oikonen, J. Bergman, T. Gronroos, E. Ferrannini, P. Nuutila, and J. Knuuti Defective Liver Disposal of Free Fatty Acids in Patients with Impaired Glucose Tolerance J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3496 - 3502. [Abstract] [Full Text] [PDF]

				A. Adkins, R. Basu, M. Persson, B. Dicke, P. Shah, A. Vella, W. F. Schwenk, and R. Rizza Higher Insulin Concentrations Are Required to Suppress Gluconeogenesis Than Glycogenolysis in Nondiabetic Humans Diabetes, September 1, 2003; 52(9): 2213 - 2220. [Abstract] [Full Text] [PDF]

				P. Iozzo, K. Hallsten, V. Oikonen, K. A. Virtanen, R. Parkkola, J. Kemppainen, O. Solin, F. Lonnqvist, E. Ferrannini, J. Knuuti, et al. Effects of Metformin and Rosiglitazone Monotherapy on Insulin-Mediated Hepatic Glucose Uptake and Their Relation to Visceral Fat in Type 2 Diabetes Diabetes Care, July 1, 2003; 26(7): 2069 - 2074. [Abstract] [Full Text] [PDF]

				P. Iozzo, K. Hallsten, V. Oikonen, K. A. Virtanen, J. Kemppainen, O. Solin, E. Ferrannini, J. Knuuti, and P. Nuutila Insulin-Mediated Hepatic Glucose Uptake Is Impaired in Type 2 Diabetes: Evidence for a Relationship with Glycemic Control J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2055 - 2060. [Abstract] [Full Text] [PDF]

				P. Shah, A. Vella, A. Basu, R. Basu, A. Adkins, W. F. Schwenk, C. M. Johnson, K. S. Nair, M. D. Jensen, and R. A. Rizza Elevated Free Fatty Acids Impair Glucose Metabolism in Women: Decreased Stimulation of Muscle Glucose Uptake and Suppression of Splanchnic Glucose Production During Combined Hyperinsulinemia and Hyperglycemia Diabetes, January 1, 2003; 52(1): 38 - 42. [Abstract] [Full Text] [PDF]

				P. Georg, A. Kautzky-Willer, K. Mahdjoobian, A. Hofer, R. Prager, G. Pacini, and B. H. Ludvik Influence of Metabolic Control on Splanchnic Glucose Uptake, Insulin Sensitivity, and the Time Required for Glucose Absorption in Patients With Type 1 Diabetes Diabetes Care, November 1, 2002; 25(11): 2042 - 2047. [Abstract] [Full Text] [PDF]

				M. Bajaj, T. Pratipanawatr, R. Berria, W. Pratipanawatr, S. Kashyap, K. Cusi, L. Mandarino, and R. A. DeFronzo Free Fatty Acids Reduce Splanchnic and Peripheral Glucose Uptake in Patients With Type 2 Diabetes Diabetes, October 1, 2002; 51(10): 3043 - 3048. [Abstract] [Full Text] [PDF]

				A. Vella, P. Shah, R. Basu, A. Basu, M. Camilleri, W. F. Schwenk, and R. A. Rizza Effect of enteral vs. parenteral glucose delivery on initial splanchnic glucose uptake in nondiabetic humans Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E259 - E266. [Abstract] [Full Text] [PDF]

				P. Shah, A. Vella, A. Basu, R. Basu, A. Adkins, W. F. Schwenk, C. M. Johnson, K. S. Nair, M. D. Jensen, and R. A. Rizza Effects of Free Fatty Acids and Glycerol on Splanchnic Glucose Metabolism and Insulin Extraction in Nondiabetic Humans Diabetes, February 1, 2002; 51(2): 301 - 310. [Abstract] [Full Text] [PDF]

				M. Shiota, M. C. Moore, P. Galassetti, M. Monohan, D. W. Neal, G. I. Shulman, and A. D. Cherrington Inclusion of Low Amounts of Fructose With an Intraduodenal Glucose Load Markedly Reduces Postprandial Hyperglycemia and Hyperinsulinemia in the Conscious Dog Diabetes, February 1, 2002; 51(2): 469 - 478. [Abstract] [Full Text] [PDF]

				B. R. Landau Methods for measuring glycogen cycling Am J Physiol Endocrinol Metab, September 1, 2001; 281(3): E413 - E419. [Abstract] [Full Text] [PDF]

				A. Gastaldelli, E. Toschi, M. Pettiti, S. Frascerra, A. Quinones-Galvan, A. M. Sironi, A. Natali, and E. Ferrannini Effect of Physiological Hyperinsulinemia on Gluconeogenesis in Nondiabetic Subjects and in Type 2 Diabetic Patients Diabetes, August 1, 2001; 50(8): 1807 - 1812. [Abstract] [Full Text] [PDF]

				A. Basu, R. Basu, P. Shah, A. Vella, C. M. Johnson, M. Jensen, K. S. Nair, W. F. Schwenk, and R. A. Rizza Type 2 Diabetes Impairs Splanchnic Uptake of Glucose but Does Not Alter Intestinal Glucose Absorption During Enteral Glucose Feeding: Additional Evidence for a Defect in Hepatic Glucokinase Activity Diabetes, June 1, 2001; 50(6): 1351 - 1362. [Abstract] [Full Text]

				A. Basu, R. Basu, P. Shah, A. Vella, R. A. Rizza, and M. D. Jensen Systemic and regional free fatty acid metabolism in type 2 diabetes Am J Physiol Endocrinol Metab, June 1, 2001; 280(6): E1000 - E1006. [Abstract] [Full Text] [PDF]

				K.-S. Park, K.-J. Nam, J.-W. Kim, Y.-B. Lee, C.-Y. Han, J.-K. Jeong, H.-K. Lee, and Y. K. Pak Depletion of mitochondrial DNA alters glucose metabolism in SK-Hep1 cells Am J Physiol Endocrinol Metab, June 1, 2001; 280(6): E1007 - E1014. [Abstract] [Full Text] [PDF]

				A. Vella, P. Shah, R. Basu, A. Basu, M. Camilleri, F. W. Schwenk, J. J. Holst, and R. A. Rizza Effect of Glucagon-Like Peptide-1(7-36)-Amide on Initial Splanchnic Glucose Uptake and Insulin Action in Humans With Type 1 Diabetes Diabetes, March 1, 2001; 50(3): 565 - 572. [Abstract] [Full Text]

				M. G. Bischof, M. Krssak, M. Krebs, E. Bernroider, H. Stingl, W. Waldhäusl, and M. Roden Effects of Short-Term Improvement of Insulin Treatment and Glycemia on Hepatic Glycogen Metabolism in Type 1 Diabetes Diabetes, February 1, 2001; 50(2): 392 - 398. [Abstract] [Full Text]

				P. Shah, A. Vella, A. Basu, R. Basu, W. F. Schwenk, and R. A. Rizza Lack of Suppression of Glucagon Contributes to Postprandial Hyperglycemia in Subjects with Type 2 Diabetes Mellitus J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4053 - 4059. [Abstract] [Full Text]